STRATA Skin Sciences Revenue, Profits - SSKN Quarterly Income Statement

Add to My Stocks
$2.09 $0.09 (4.5%) SSKN stock closing price Jun 18, 2018 (Closing)

Fundamental analysis of SSKN stock involves analyzing its financial statements, apart from checking the STRATA Skin Sciences stock price. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the SSKN stock is bound to reflect the impact of the QOQ decline of -24.88%. One also needs to look at STRATA Skin Sciences assets, operating expenses and STRATA Skin Sciences free cash flow. The STRATA Skin Sciences profit and loss statement shows revenue of $6.46M for 2018 Q1. Revenue has decreased by -24.88% QoQ for SSKN stock.

View and download details of revenue and profits for STRATA Skin Sciences for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
STRATA Skin Sciences Revenues or Net Sales
6.46M8.6M7.48M8.7M7.27M8.63M7.77M7.74M7.62M9.48M
Cost Of Goods Sold (COGS)3.29M4.32M3.27M3.17M2.73M3.01M3.07M3.13M3.42M3.49M
STRATA Skin Sciences Gross Profit
3.17M3.7M4.2M5.52M4.53M5.64M4.69M4.6M4.19M5.97M
Research & Development Expense---------1.04M
Selling General & Admin Expense4.67M4.75M4.36M4.79M4.75M4.83M4.72M5.42M5.81M6.47M
Income Before Depreciation Depletion Amortization-1.84M-1.46M-0.57M--0.68M--0.4M-1.45M-2.13M-1.52M
Depreciation Depletion Amortization----------
Non Operating Income---11.71M--0.13M--3.19M1.98M2.49M
Interest Expense--1.34M1.57M1.34M1.35M1.17M1.17M1.21M1.48M
STRATA Skin Sciences Pretax Income
-2.18M-1.78M-13.63M-1.13M-2.16M-0.82M-1.44M--1.37M-0.48M
Provision for Income Taxes--0.05M--------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-2.22M-1.72M-13.67M-1.21M-2.24M-0.88M-1.51M--1.44M-0.59M
Extraordinary Items & Discontinued Operations----------
STRATA Skin Sciences Profit/ Loss (Net Income)
-2.22M-1.72M-13.67M-1.21M-2.24M-0.88M-1.51M--1.44M-0.59M
Average Shares used to compute Diluted EPS-3.86M2.48M2.33M2.18M2.15M2.14M2.31M2.66M2.03M
Average Shares used to compute Basic EPS-3.86M2.48M2.33M2.18M2.15M2.14M2.12M2.07M2.03M
Income Before Nonrecurring Items--1.72M-1.87M-1.21M-2.1M-0.88M-1.51M--1.44M-2.21M
Income from Nonrecurring Items---11.8M--0.13M----1.62M
STRATA Skin Sciences Earnings Per Share Basic Net
-0.13-0.10-5.52-0.52-1.03-0.40-0.700.25-0.70-0.30
STRATA Skin Sciences Earnings Per Share Diluted Net
-0.13-0.10-5.52-0.52-1.03-0.45-0.70-1.15-1.30-0.30
EPS Diluted Before Nonrecurring Items--0.10-0.76-0.52-0.97-0.45-0.70-1.15-1.30-1.10
Preferred Dividends Acc Pd--1.33M--------
Dividends Common0.000.00--------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The key things to look for in an income statement while doing STRATA Skin Sciences stock analysis are:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that SSKN stock has a topline or revenue of $6.46M for 2018 Q1 as per this STRATA Skin Sciences revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-2.22M for STRATA Skin Sciences for 2018 Q1. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the SSKN income statement, one can check the STRATA Skin Sciences historical stock prices to check how the price has moved with time.

STRATA Skin Sciences Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
0.26
Dividend Yield
0%